As the ARID1A and ARID1B proteins are mutually exclusive in the SWI/SNF complex, it could be proposed that the survival of tumor cells with ARID1A mutations may depend on the presence of ARID1B in the residual SWI/SNF complex. The gene discussed is SMARCA1; the disease is neoplasm.